Luye Pharma Group Ltd.

LYPHF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$4,937$3,239$2,324$2,438
Short-Term Investments$1,566$1,272$3,221$3,072
Receivables$4,301$2,588$1,784$1,765
Inventory$912$828$773$746
Other Curr. Assets$1,592$1,181$2,685$2,375
Total Curr. Assets$13,308$10,703$10,786$10,397
Property Plant & Equip (Net)$5,891$5,089$4,909$4,594
Goodwill$1,012$1,042$1,003$985
Intangibles$6,585$4,805$5,985$5,442
Long-Term Investments$926$697-$2,106-$2,490
Tax Assets$164$1,272$114$133
Other NC Assets$1,725$3,155$3,559$3,520
Total NC Assets$16,304$14,787$13,464$12,185
Other Assets$0$0$0$0
Total Assets$29,612$25,491$24,250$22,582
Liabilities
Payables$689$767$560$571
Short-Term Debt$7,585$5,196$6,840$5,263
Tax Payable$435$295$256$205
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,060$1,880$1,831$1,291
Total Curr. Liab.$10,769$8,138$9,487$7,330
LT Debt$2,736$3,228$2,265$4,228
Deferred Rev, NC$118$0$175$209
Deferred Tax Liab, NC$36$0$56$58
Other NC Liab.$199$596$1,456$1,910
Total NC Liab.$3,089$3,824$3,721$6,138
Other Liabilities$0$0$0$0
Cap. Leases$62$71$38$42
Total Liabilities$13,859$11,962$13,208$13,468
Equity
Pref Stock$0$0$0$0
Common Stock$486$486$457$456
Retained Earnings$0$7,381$6,667$6,062
AOCI$0$505$254$534
Other Equity$13,668$4,159$2,797$1,436
Total Equity$14,155$12,531$10,176$8,488
Supplemental Information
Minority Interest$1,599$997$866$626
Total Liab. & Tot. Equity$29,612$25,491$24,250$22,582
Net Debt$5,384$5,185$6,781$7,053